Sepsis Diagnostics Companies

ID: MRFR/MED/1574-HCR

85 Pages

Satyendra Maurya

Last Updated: February 16, 2025

Sepsis diagnostics companies specialize in developing advanced medical technologies to swiftly and accurately identify sepsis, a life-threatening condition resulting from the body's extreme response to infection. These innovative firms employ cutting-edge methods, such as molecular diagnostics, biomarker analysis, and artificial intelligence algorithms, to detect sepsis markers in blood samples.

Sepsis Diagnostics Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)7.1%

2025 Market SizeUSD 0.85 Billion

2035 Market SizeUSD 1.69 Billion

Key Players

bioMérieux

Becton Dickinson

Roche Diagnostics

Danaher

Thermo Fisher Scientific

Abbott Laboratories

Trends

Rising Global Sepsis Incidence
Hospital-Acquired Infection Burden
Regulatory Reimbursement Mandates

Opportunities

Point-of-Care Sepsis Testing in Emergency Departments
AI-Enabled Clinical Decision Support Integration
Emerging Market Hospital Modernization

Summary Table of Contents Segmentation Methodology Download PDF

Customize Report

Certified Researchers

Top Industry Leaders in the Sepsis Diagnostics Market

Latest Sepsis Diagnostics Companies Update

December 2023: Legend Biotech receives China National Medical Products Administration (NMPA) approval for LCAR-017 for relapsed/refractory B-cell lymphomas. This signifies the first regulatory approval for CAR T-cell therapy in China.November 2023: BioMarker has raised $30 million in a Series B funding round, demonstrating investor confidence in the company's AI-powered platform for analyzing brain scans and improving diagnosis of neurological disorders. Jan 2024: BlueRock Therapeutics releases encouraging Phase I/II data for autologous T-cell therapy for PD-L1 negative non-small cell lung cancer. this marks progress in tackling challenging cancer types with autologous therapies.October 2023: CTI BioTech's blood test for early sepsis detection, SepsiSTAT, wins FDA Breakthrough Device Designation. This could expedite the approval process and bring the test to market faster.Jan 2024: Magenta Therapeutics secures $165 million in Series D funding, aiming to advance product development and manufacturing capabilities.August 2023: Novartis expands CAR-T program partnership with Cellares, demonstrating continued commitment to CAR T-cell therapy development.

List of Sepsis Diagnostics Key Companies in the Market

Sandstone Diagnostics Inc. (US)
T2 Biosystems
Immunexpress (US)
Axis-Shield Diagnostics Ltd. (Scotland)
Becton Dickinson and Company (US)
EKF Diagnostics (UK)
Cube Dx GmbH (Austria)
Wolters Kulwer N.V. (Netherlands)
Amara Health (US)

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”